Literature DB >> 12358171

The effect of sex on ventricular arrhythmic events in patients with congestive heart failure.

Doron Aronson1, Andrew J Burger.   

Abstract

The propensity to develop specific arrhythmias varies between the sexes. Patients with congestive heart failure (CHF) have a high prevalence of ventricular ectopy. However, it is not known if sex related differences exist in the susceptibility to arrhythmias in the setting of CHF. The study population included 159 men and 77 women (mean age 61 +/- 14 years) admitted for decompensated CHF. The severity of atrial and ventricular arrhythmias was assessed by 24-hour Holter monitoring. None of the patients were on parenteral vasoactive therapy during Holter recording. All measures of ventricular ectopy were markedly lower in women compared to men. The mean hourly ventricular pairs (283 +/- 67 vs 106 +/- 30, P = 0.04), mean hourly repetitive ventricular beats (28 +/- 7 vs 10 +/- 3, P = 0.04), and the frequency of ventricular tachycardia episodes per 24 hours (31 +/- 9 vs 7 +/- 3, P = 0.01) were significantly lower in women. After inclusion of clinical variables and drug therapies in a multivariate analysis, the negative relationship between female sex and the frequency of ventricular pairs (P = 0.04), repetitive ventricular beats (P = 0.04), and ventricular tachycardia episodes (P = 0.0005) remained independent. No differences in atrial ectopy between men and woman were found. Complex ventricular ectopy and episodes of ventricular tachycardia are significantly lower in women with CHF. Whether these finding are relevant to female survival advantage in the setting of heartfailure can only be determined by a prospective study. Further understanding of the mechanisms involved in the protection conferred by the patient's sex would advance our understanding about arrhythmias in heart failure.

Entities:  

Mesh:

Year:  2002        PMID: 12358171     DOI: 10.1046/j.1460-9592.2002.01206.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry.

Authors:  Rui Providência; Eloi Marijon; Pier D Lambiase; Abdeslam Bouzeman; Pascal Defaye; Didier Klug; Denis Amet; Marie-Cécile Perier; Daniel Gras; Vincent Algalarrondo; Jean-Claude Deharo; Christophe Leclercq; Laurent Fauchier; Dominique Babuty; Pierre Bordachar; Nicolas Sadoul; Olivier Piot; Serge Boveda
Journal:  J Am Heart Assoc       Date:  2016-02-12       Impact factor: 5.501

2.  Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries.

Authors:  Christian Sticherling; Barbora Arendacka; Jesper Hastrup Svendsen; Sofieke Wijers; Tim Friede; Jochem Stockinger; Michael Dommasch; Bela Merkely; Rik Willems; Andrzej Lubinski; Michael Scharfe; Frieder Braunschweig; Martin Svetlosak; Christine S Zürn; Heikki Huikuri; Panagiota Flevari; Caspar Lund-Andersen; Beat A Schaer; Anton E Tuinenburg; Leonard Bergau; Georg Schmidt; Gabor Szeplaki; Bert Vandenberk; Emilia Kowalczyk; Christian Eick; Juhani Juntilla; David Conen; Markus Zabel
Journal:  Europace       Date:  2018-06-01       Impact factor: 5.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.